Lrrc6 Gene Primary Ciliary Dyskinesia Type 19 NGS Genetic DNA Test
Introduction
The Lrrc6 Gene Primary Ciliary Dyskinesia Type 19 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify mutations in the LRRC6 gene, which are associated with primary ciliary dyskinesia (PCD). This condition affects the movement of cilia, leading to various respiratory and fertility issues. Early diagnosis through this test is crucial for effective management and treatment of PCD.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to detect specific mutations in the LRRC6 gene. By analyzing a blood sample or extracted DNA, the test can reveal whether an individual has inherited the genetic markers associated with primary ciliary dyskinesia type 19.
Who Should Consider This Test?
Individuals experiencing symptoms such as chronic respiratory infections, reduced fertility, or abnormal organ positioning should consider this test. Additionally, those with a family history of primary ciliary dyskinesia or related genetic disorders may also benefit from testing.
Benefits of Taking the Test
- Early identification of primary ciliary dyskinesia can lead to timely interventions.
- Understanding genetic risks can help in family planning and management.
- Provides clarity for patients and families regarding symptoms and potential treatments.
Understanding Your Results
Results from the Lrrc6 Gene Primary Ciliary Dyskinesia Type 19 NGS Genetic DNA Test will indicate whether mutations are present. A genetic counseling session is recommended to help interpret the results and discuss implications for health and family.
Test Pricing
| Discount Price | 400000 NGN |
|---|---|
| Regular Price | 560000 NGN |
Book Your Test Today!
Don’t wait to get the answers you need. To book the Lrrc6 Gene Primary Ciliary Dyskinesia Type 19 NGS Genetic DNA Test, call or WhatsApp us at +2348077798758 for more details and assistance.
